Dimensional Fund Advisors’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.6M | Buy |
|
|||||
|
2025
Q1 | $21.3M | Buy |
|
|||||
|
2024
Q4 | $12.5M | Buy |
|
|||||
|
2024
Q3 | $204K | Sell |
|
|||||
|
2024
Q2 | $426K | Sell |
|
|||||
|
2024
Q1 | $1.15M | Buy |
|
|||||
|
2023
Q4 | $489K | Sell |
|
|||||
|
2023
Q3 | $5.18M | Sell |
|
|||||
|
2023
Q2 | $12.6M | Sell |
|
|||||
|
2023
Q1 | $10.8M | Sell |
|
|||||
|
2022
Q4 | $15.9K | Sell |
|
|||||
|
2022
Q3 | $9.92M | Sell |
|
|||||
|
2022
Q2 | $3.42M | Buy |
|
|||||
|
2022
Q1 | $4.79M | Buy |
|
|||||
|
2021
Q4 | $5.34M | Buy |
|
|||||
|
2021
Q3 | $4.7M | Sell |
|
|||||
|
2021
Q2 | $5.34M | Buy |
|
|||||
|
2021
Q1 | $948K | Sell |
|
|||||
|
2020
Q4 | $1.27M | Buy |
|